dc.contributor.author | Çirak, Selen | |
dc.contributor.author | TÜZÜN, Erdem | |
dc.contributor.author | Koral, Gizem | |
dc.contributor.author | Günaydin, Sefer | |
dc.contributor.author | Baştan, Birgül | |
dc.contributor.author | Bayar, Muhammet Duran | |
dc.contributor.author | Şişman, Aysel Büşra | |
dc.date.accessioned | 2023-02-21T08:22:50Z | |
dc.date.available | 2023-02-21T08:22:50Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Bayar M. D., Şişman A. B., Koral G., Çirak S., TÜZÜN E., Günaydin S., Baştan B., "INCREASED SERUM CITRULLINATED HISTONE H3 LEVELS IN COVID-19 PATIENTS WITH ACUTE ISCHEMIC STROKE AKUT ISCHAEMIÁS STROKE-BAN SZENVEDÔ COVID-19-BETEGEK KÖRÉBEN MEGNÔ A SZÉRUM CITRULLINÁLT HISZTON H3-SZINTJE", Ideggyogyaszati Szemle, cilt.75, sa.5-6, ss.191-198, 2022 | |
dc.identifier.issn | 0019-1442 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_199388c5-c92c-46a9-9081-20a6526c8025 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/186605 | |
dc.identifier.uri | https://doi.org/10.18071/isz.75.0191 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85132778104&origin=inward | |
dc.description.abstract | © 2022 Ifjusagi Lap-es Konyvkiado Vallalat. All rights reserved.Background and purpose – Prevalence of acute ischemic stroke (AIS) is increased in patients with coronavirus disease 2019 (COVID-19). A proposed hypothesis is increased virus-induced propensity to hypercoagulation resulting in arterial thrombosis. Our aim was to provide evidence regarding the involvement of neutrophil extracellular trap (NET) formation (NETosis) in COVID-19 related AIS. Methods – Twenty-six consecutively enrolled COVID-19+ pneumonia patients with AIS, 32 COVID-19+ pneumonia patients without AIS and 24 AIS patients without COVID-19 infection were included to the study. Clinical characteristics of recruited patients were collected. Serum levels of citrullinated histone H3 (H3Cit; a factor of NETosis), IL-8 and C5a (mediators associated with NETosis) were measured by ELISA (enzyme-linked immunosorbent assay). Results – H3Cit levels were significantly higher in COVID-19+ AIS patients, whereas all study groups showed comparable IL-8 and C5a levels. There were no significant differences among etiological subgroups of AIS patients with or without COVID-19. AIS patients with COVID-19 showed relatively increased white blood cell, lymphocyte, neutrophil, D-dimer, C-reactive protein and procalcitonin levels than control groups. H3Cit levels did not correlate with clinical/prognostic features and inflammation parameters. H3Cit and IL-8 levels were correlated in COVID-19 patients without stroke but not in COVID-19 positive or negative AIS patients. Conclusion – Increased levels of inflammation parameters and H3Cit in COVID-19 related AIS suggest that NETosis may cause susceptibility to arterial thrombosis. However, H3Cit levels do not correlate with clinical severity measures and inflammation parameters diminishing the prognostic biomarker value of NETosis factors. Moreover, the link between IL-8 and NETosis appears to be abolished in AIS. | |
dc.language.iso | eng | |
dc.subject | Neurology (clinical) | |
dc.subject | Health Sciences | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Neurology | |
dc.subject | Life Sciences | |
dc.subject | Nöroloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NÖROLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.title | INCREASED SERUM CITRULLINATED HISTONE H3 LEVELS IN COVID-19 PATIENTS WITH ACUTE ISCHEMIC STROKE AKUT ISCHAEMIÁS STROKE-BAN SZENVEDÔ COVID-19-BETEGEK KÖRÉBEN MEGNÔ A SZÉRUM CITRULLINÁLT HISZTON H3-SZINTJE | |
dc.type | Makale | |
dc.relation.journal | Ideggyogyaszati Szemle | |
dc.contributor.department | University of Health Sciences , , | |
dc.identifier.volume | 75 | |
dc.identifier.issue | 5-6 | |
dc.identifier.startpage | 191 | |
dc.identifier.endpage | 198 | |
dc.contributor.firstauthorID | 3434265 | |